
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7540549
[patent_doc_number] => 08058392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-15
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 12/895946
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10355
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/058/08058392.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895946
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895946 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6149311
[patent_doc_number] => 20110020906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/896041
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10359
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020906.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896041 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6149310
[patent_doc_number] => 20110020905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/895967
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10362
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895967 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 7545583
[patent_doc_number] => 08053555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 12/895955
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10328
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895955
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895955 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6149307
[patent_doc_number] => 20110020902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/895933
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10363
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895933
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895933 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 7515511
[patent_doc_number] => 08039583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 12/895899
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10355
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039583.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895899 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6196558
[patent_doc_number] => 20110028316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/896061
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10356
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028316.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896061 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 7515512
[patent_doc_number] => 08039584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-18
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 12/895904
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10381
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039584.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895904 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6120643
[patent_doc_number] => 20110077164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'EXPRESSION PROFILING PLATFORM TECHNOLOGY'
[patent_app_type] => utility
[patent_app_number] => 12/889935
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9574
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077164.pdf
[firstpage_image] =>[orig_patent_app_number] => 12889935
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/889935 | EXPRESSION PROFILING PLATFORM TECHNOLOGY | Sep 23, 2010 | Abandoned |
Array
(
[id] => 5977592
[patent_doc_number] => 20110071046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'MATRIX SCREENING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/888862
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10948
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071046.pdf
[firstpage_image] =>[orig_patent_app_number] => 12888862
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/888862 | MATRIX SCREENING METHOD | Sep 22, 2010 | Abandoned |
Array
(
[id] => 6083648
[patent_doc_number] => 20110144031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same'
[patent_app_type] => utility
[patent_app_number] => 12/923463
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4732
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144031.pdf
[firstpage_image] =>[orig_patent_app_number] => 12923463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/923463 | Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same | Sep 22, 2010 | Abandoned |
Array
(
[id] => 7818502
[patent_doc_number] => 20120065122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Pharmaceutical Composition and Method for Modulating Slow Myosin'
[patent_app_type] => utility
[patent_app_number] => 12/882546
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 1866
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882546
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882546 | Pharmaceutical Composition and Method for Modulating Slow Myosin | Sep 14, 2010 | Abandoned |
Array
(
[id] => 6000644
[patent_doc_number] => 20110117073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Protein Kinase Conjugates and Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/882484
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 42036
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117073.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882484 | Protein kinase conjugates and inhibitors | Sep 14, 2010 | Issued |
Array
(
[id] => 6389872
[patent_doc_number] => 20100317837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES'
[patent_app_type] => utility
[patent_app_number] => 12/869198
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17725
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12869198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/869198 | IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES | Aug 25, 2010 | Abandoned |
Array
(
[id] => 5986706
[patent_doc_number] => 20110098235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'ANTINEOPLASTIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/869314
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6584
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098235.pdf
[firstpage_image] =>[orig_patent_app_number] => 12869314
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/869314 | Antineoplastic peptides | Aug 25, 2010 | Issued |
Array
(
[id] => 9983791
[patent_doc_number] => 09029505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Modified vasoactive intestinal peptides'
[patent_app_type] => utility
[patent_app_number] => 12/857103
[patent_app_country] => US
[patent_app_date] => 2010-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13714
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12857103
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/857103 | Modified vasoactive intestinal peptides | Aug 15, 2010 | Issued |
Array
(
[id] => 6136138
[patent_doc_number] => 20110009291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY'
[patent_app_type] => utility
[patent_app_number] => 12/846646
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14547
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009291.pdf
[firstpage_image] =>[orig_patent_app_number] => 12846646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/846646 | METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY | Jul 28, 2010 | Abandoned |
Array
(
[id] => 5959531
[patent_doc_number] => 20110183918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'Method of Treating Leukemia Using Rcie Prolamin'
[patent_app_type] => utility
[patent_app_number] => 12/845039
[patent_app_country] => US
[patent_app_date] => 2010-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4726
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183918.pdf
[firstpage_image] =>[orig_patent_app_number] => 12845039
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/845039 | Method of Treating Leukemia Using Rcie Prolamin | Jul 27, 2010 | Abandoned |
Array
(
[id] => 6183444
[patent_doc_number] => 20110123448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'OIL BODY CARRIERS, USES IN TARGET THERAPY AND/OR DETECTION OF THE SAME, AND FUSION PROTEINS COMPRISED THEREIN'
[patent_app_type] => utility
[patent_app_number] => 12/841500
[patent_app_country] => US
[patent_app_date] => 2010-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 9993
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123448.pdf
[firstpage_image] =>[orig_patent_app_number] => 12841500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/841500 | OIL BODY CARRIERS, USES IN TARGET THERAPY AND/OR DETECTION OF THE SAME, AND FUSION PROTEINS COMPRISED THEREIN | Jul 21, 2010 | Abandoned |
Array
(
[id] => 5993477
[patent_doc_number] => 20110015130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/838926
[patent_app_country] => US
[patent_app_date] => 2010-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 11976
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12838926
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/838926 | Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof | Jul 18, 2010 | Abandoned |